274 related articles for article (PubMed ID: 23967066)
1. L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.
Ralph AP; Waramori G; Pontororing GJ; Kenangalem E; Wiguna A; Tjitra E; Sandjaja ; Lolong DB; Yeo TW; Chatfield MD; Soemanto RK; Bastian I; Lumb R; Maguire GP; Eisman J; Price RN; Morris PS; Kelly PM; Anstey NM
PLoS One; 2013; 8(8):e70032. PubMed ID: 23967066
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial.
Daley P; Jagannathan V; John KR; Sarojini J; Latha A; Vieth R; Suzana S; Jeyaseelan L; Christopher DJ; Smieja M; Mathai D
Lancet Infect Dis; 2015 May; 15(5):528-34. PubMed ID: 25863562
[TBL] [Abstract][Full Text] [Related]
3. High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial.
Tukvadze N; Sanikidze E; Kipiani M; Hebbar G; Easley KA; Shenvi N; Kempker RR; Frediani JK; Mirtskhulava V; Alvarez JA; Lomtadze N; Vashakidze L; Hao L; Del Rio C; Tangpricha V; Blumberg HM; Ziegler TR
Am J Clin Nutr; 2015 Nov; 102(5):1059-69. PubMed ID: 26399865
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.
Martineau AR; Timms PM; Bothamley GH; Hanifa Y; Islam K; Claxton AP; Packe GE; Moore-Gillon JC; Darmalingam M; Davidson RN; Milburn HJ; Baker LV; Barker RD; Woodward NJ; Venton TR; Barnes KE; Mullett CJ; Coussens AK; Rutterford CM; Mein CA; Davies GR; Wilkinson RJ; Nikolayevskyy V; Drobniewski FA; Eldridge SM; Griffiths CJ
Lancet; 2011 Jan; 377(9761):242-50. PubMed ID: 21215445
[TBL] [Abstract][Full Text] [Related]
6. Prevention of relapse in drug sensitive pulmonary tuberculosis patients with and without vitamin D3 supplementation: A double blinded randomized control clinical trial.
Sinha S; Thukral H; Shareef I; Desai D; Singh BK; Das BK; Dhooria S; Sarin R; Singla R; Meena SK; Pandey RM; Pandey S; Sethi S; Kajal A; Yadav R; Aggarwal AN; Bhadada S; Behera D
PLoS One; 2023; 18(3):e0272682. PubMed ID: 36996065
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of vitamin D
Sudfeld CR; Mugusi F; Muhihi A; Aboud S; Nagu TJ; Ulenga N; Hong B; Wang M; Fawzi WW
Lancet HIV; 2020 Jul; 7(7):e463-e471. PubMed ID: 32621874
[TBL] [Abstract][Full Text] [Related]
8. Effects of vitamin D supplementation on the outcomes of patients with pulmonary tuberculosis: a systematic review and meta-analysis.
Wu HX; Xiong XF; Zhu M; Wei J; Zhuo KQ; Cheng DY
BMC Pulm Med; 2018 Jun; 18(1):108. PubMed ID: 29954353
[TBL] [Abstract][Full Text] [Related]
9. High-Dose Vitamin D
Ganmaa D; Munkhzul B; Fawzi W; Spiegelman D; Willett WC; Bayasgalan P; Baasansuren E; Buyankhishig B; Oyun-Erdene S; Jolliffe DA; Xenakis T; Bromage S; Bloom BR; Martineau AR
Am J Respir Crit Care Med; 2017 Sep; 196(5):628-637. PubMed ID: 28692301
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive vitamin A and D during pulmonary tuberculosis treatment: a randomized controlled trial with a 2 × 2 factorial design.
Wang J; Xiong K; Wang Q; Zhao S; Liu Y; Ma A
Food Funct; 2020 May; 11(5):4672-4681. PubMed ID: 32406431
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant data.
Jolliffe DA; Ganmaa D; Wejse C; Raqib R; Haq MA; Salahuddin N; Daley PK; Ralph AP; Ziegler TR; Martineau AR
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30728208
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
13. Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis.
Schön T; Elias D; Moges F; Melese E; Tessema T; Stendahl O; Britton S; Sundqvist T
Eur Respir J; 2003 Mar; 21(3):483-8. PubMed ID: 12662006
[TBL] [Abstract][Full Text] [Related]
14. L-arginine and vitamin D: novel adjunctive immunotherapies in tuberculosis.
Ralph AP; Kelly PM; Anstey NM
Trends Microbiol; 2008 Jul; 16(7):336-44. PubMed ID: 18513971
[TBL] [Abstract][Full Text] [Related]
15. High-dose oral vitamin D supplementation and mortality in people aged 65-84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation.
Rake C; Gilham C; Bukasa L; Ostler R; Newton M; Peto Wild J; Aigret B; Hill M; Gillie O; Nazareth I; Sasieni P; Martineau A; Peto J
Health Technol Assess; 2020 Feb; 24(10):1-54. PubMed ID: 32090730
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of zinc and vitamin A as co-adjuvants for the treatment of pulmonary tuberculosis.
Lawson L; Thacher TD; Yassin MA; Onuoha NA; Usman A; Emenyonu NE; Shenkin A; Davies PD; Cuevas LE
Trop Med Int Health; 2010 Dec; 15(12):1481-90. PubMed ID: 20958890
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial.
Wallis RS; Ginindza S; Beattie T; Arjun N; Likoti M; Edward VA; Rassool M; Ahmed K; Fielding K; Ahidjo BA; Vangu MDT; Churchyard G
Lancet Respir Med; 2021 Aug; 9(8):897-908. PubMed ID: 33740465
[TBL] [Abstract][Full Text] [Related]
18. Improvement cues of lesion absorption using the adjuvant therapy of traditional Chinese medicine Qinbudan tablet for retreatment pulmonary tuberculosis with standard anti-tuberculosis regimen.
Zhang SY; Fu JY; Guo XY; Wu DZ; Zhang T; Li C; Qiu L; Shao CR; Xiao HP; Chu NH; Deng QY; Zhang X; Yan XF; Wang ZL; Zhang ZJ; Jiang X; Zheng YJ; Zheng PY; Zhang HY; Lu ZH
Infect Dis Poverty; 2020 May; 9(1):50. PubMed ID: 32381098
[TBL] [Abstract][Full Text] [Related]
19. Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial.
Mily A; Rekha RS; Kamal SM; Arifuzzaman AS; Rahim Z; Khan L; Haq MA; Zaman K; Bergman P; Brighenti S; Gudmundsson GH; Agerberth B; Raqib R
PLoS One; 2015; 10(9):e0138340. PubMed ID: 26394045
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.
Wejse C; Gomes VF; Rabna P; Gustafson P; Aaby P; Lisse IM; Andersen PL; Glerup H; Sodemann M
Am J Respir Crit Care Med; 2009 May; 179(9):843-50. PubMed ID: 19179490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
